Compile Data Set for Download or QSAR
Report error Found 14 Enz. Inhib. hit(s) with all data for entry = 10496
TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541401(US11267808, Example 1 | 2-chloro-5-cyano-N-(2-phen...)
Affinity DataIC50: 200nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541402(US11267808, Example 2 | 2-chloro-5-cyano-N-(6-phen...)
Affinity DataIC50: 200nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541404(2-chloro-5-cyano-N-(6-(4- fluorophenyl)pyridin-3-y...)
Affinity DataIC50: 200nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541405(N-([2,3'-bipyridin]-5-yl)-2-chloro-5- cyanobenzami...)
Affinity DataIC50: 200nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541408(N-([2,3'-bipyridin]-5-yl)-5-cyano-2- fluorobenzami...)
Affinity DataIC50: 200nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541409(5-cyano-2-fluoro-N-(6-(4- fluorophenyl)pyridin-3-y...)
Affinity DataIC50: 200nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541410(N-([2,2'-bipyridin]-5-yl)-2-chloro-5- cyanobenzami...)
Affinity DataIC50: 200nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541403(2-chloro-5-cyano-N-(2-(4- fluorophenyl)pyridin-4-y...)
Affinity DataIC50: 600nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541406(N-([2,3'-bipyridin]-4-yl)-2-chloro-5- cyanobenzami...)
Affinity DataIC50: 2.55E+4nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541407(N-([2,4'-bipyridin]-5-yl)-2-chloro-5- cyanobenzami...)
Affinity DataIC50: 2.55E+4nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541411(2-chloro-5-cyano-N-(6-(4- methylpiperazin-1-yl)pyr...)
Affinity DataIC50: 2.55E+4nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541413(2-chloro-5-cyano-N-(2- morpholinopyridin-4-yl)benz...)
Affinity DataIC50: 2.55E+4nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541414(2-chloro-5-cyano-N-(6- morpholinopyridin-3-yl)benz...)
Affinity DataIC50: 2.55E+4nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent

TargetPeroxisome proliferator-activated receptor gamma(Human)
Medibiofarma

US Patent
LigandPNGBDBM541412(2-chloro-5-cyano-N-(2-(4- methylpiperazin-1-yl)pyr...)
Affinity DataIC50: 5.00E+4nMAssay Description:The IC50 values (concentration causing a half-maximal inhibition of control specific binding) was determined by non-linear regression analysis of the...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
Go to US Patent